Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Genomics ace quits Japan

Subjects

Yusuke Nakamura blames government inertia for his move to the United States.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cyranoski, D. Nature 424, 359 (2003).

    Article  ADS  CAS  Google Scholar 

  2. Cyranoski, D. Nature 464, 22–24 (2010).

    Article  CAS  Google Scholar 

  3. The International HapMap Consortium Nature 437, 1299–1320 (2005).

  4. Cyranoski, D. Nature 443, 382 (2006).

    Article  ADS  CAS  Google Scholar 

  5. Cyranoski, D. Nature 474, 136 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Related links

Related links

Related links in Nature Research

A healthier Japan 2011-Jun-07

'Big science' protein project under fire 2006-Sep-27

Science lessons 2005-Jan-12

Japan launches controversial Biobank project 2003-Aug-01

Dispute over data privacy halts cancer study 2003-Jul-24

Japan earthquake and nuclear crisis

HapMap focus

Related external links

BioBank Japan

International HapMap Project

International Cancer Genome Consortium

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cyranoski, D. Genomics ace quits Japan. Nature 482, 18–19 (2012). https://doi.org/10.1038/482018a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/482018a

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research